Clinical Trials Browser

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

NCT03221426 2026-03-09

KEYNOTE-585

Phase 3 Completed

1,007 enrolled 25 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03635567 2026-02-04

KEYNOTE-826

Phase 3 Completed

617 enrolled 29 charts 1 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT06910514 2025-04-09

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

Phase 3 Completed

52 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT03515837 2024-11-22

MK-3475-789

Phase 3 Completed

492 enrolled 21 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02578680 2024-09-20

MK-3475-189

Phase 3 Completed

616 enrolled 19 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04799249 2024-08-01

PRESERVE 2

Phase 3 Completed

194 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03950674 2024-06-10

MK-3475-189

Phase 3 Completed

40 enrolled 20 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT01685398 2023-09-21

Topical Timolol for Superficial Infantile Hemangioma

Phase 3 Completed

48 enrolled

Hemangioma

NCT03066778 2022-10-03

KEYNOTE-604

Phase 3 Completed

453 enrolled 23 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Small Cell Lung Carcinoma

NCT02453334 2021-05-11

IRON CLAD

Phase 3 Completed

244 enrolled 33 charts

Tumor-Agnostic

Neoplasms

NCT01715597 2017-10-31

Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

Phase 3 Completed

50 enrolled

Myofibroma

NCT01725789 2016-12-16

Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)

Phase 3 Completed

454 enrolled

Classical hematology

Anemia

NCT00583323 2014-08-21

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

Phase 3 Completed

60 enrolled

Lymphoid

Lymphoma

NCT00951574 2012-02-01

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Phase 3 Completed

1,166 enrolled

Neoplasm Metastasis, Neoplasms, Thromboembolism

Clinical Trials

KEYNOTE-564

KEYNOTE-585

KEYNOTE-826

KEYNOTE-921

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

ERA 223

MK-3475-789

MK-3475-189

PRESERVE 2

MK-3475-189

Topical Timolol for Superficial Infantile Hemangioma

KEYNOTE-604

IRON CLAD

Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma

Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)

Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)